Coeptis Therapeutics Holdings Inc
COEPW0.029USD
-0.001-2.39%
Market hours （ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
More Details of Coeptis Therapeutics Holdings Inc Company
Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its product portfolio is highlighted by assets licensed from Deverra Therapeutics, including an allogeneic cellular immunotherapy platform and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. It is developing a universal, multi-antigen CAR technology licensed from the University of Pittsburgh (SNAP-CAR), and the GEAR cell therapy and companion diagnostic platforms in collaboration with VyGen-Bio and medical researchers at the Karolinska Institute. Its NexGenAI Affiliates Network platform offers AI-powered marketing software and advanced robotic process automation capabilities. Its Coeptis Technologies division is focused on diversifying and enhancing its growth potential. Its subsidiaries include Coeptis Therapeutics, Inc., Coeptis Pharmaceuticals, Inc., GEAR Therapeutics, Inc. and SNAP Biosciences, Inc.
Company Info
Ticker SymbolCOEPW
Company nameCoeptis Therapeutics Holdings Inc
IPO dateDec 17, 2020
CEO- -
Number of employees- -
Security typeCompany Warrant
Fiscal year-end- -
Address105 Bradford Road, Suite 420
CityWEXFORD
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code15090
Phone17249346467
Websitehttps://coeptistx.com/
Ticker SymbolCOEPW
IPO dateDec 17, 2020
CEO- -
Company Executives
Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Wed, Jul 2
Updated: Wed, Jul 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Other
100.00%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
25
830.98K
0.00%
-949.99K
2025Q1
26
830.98K
0.00%
-1.05M
2024Q4
29
1.01M
0.00%
-1.53M
2024Q3
33
1.78M
0.00%
-1.61M
2024Q2
34
2.07M
0.00%
-1.33M
2024Q1
34
2.12M
0.00%
-666.88K
2023Q4
33
1.49M
0.00%
-1.25M
2023Q3
31
1.50M
0.00%
-1.41M
2023Q2
30
2.00M
0.00%
-919.99K
2023Q1
30
2.08M
0.00%
-754.61K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Osaic Holdings, Inc.
17.47K
0%
+17.47K
--
Mar 31, 2025
HRT Financial LP
--
0%
-100.11K
-100.00%
Sep 30, 2024
IONIC Capital Management, L.L.C.
--
0%
-93.56K
-100.00%
Dec 31, 2024
Meteora Capital LLC
252.23K
0%
-174.84K
-40.94%
Mar 31, 2025
RiverNorth Capital Management LLC
150.00K
0%
--
--
Mar 31, 2025
Walleye Trading, LLC
131.27K
0%
-2.91K
-2.17%
Mar 31, 2025
Cantor Fitzgerald, L.P
106.46K
0%
--
--
Mar 31, 2025
Skyview Investment Advisors, LLC
55.12K
0%
--
--
Dec 31, 2024
CSS, LLC
38.85K
0%
--
--
Mar 31, 2025
Landscape Capital Management, L.L.C.
32.05K
0%
--
--
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
